JellyBlue Ashwagandha Dose Check: 100 mg vs the 600 mg Study They Cite

This is the clearest checkable claim on the entire sales page, and it takes about four minutes to verify. The page names a study, quotes its headline result, and sells a product carrying a sixth of the dose that study used.

What the page claims

Under its research section, the official page describes a double-blind, randomised, placebo-controlled trial published in 2015 in a sports nutrition journal, reporting that men supplementing with ashwagandha root extract for eight weeks saw a 17% increase in testosterone, a large increase in sperm count, and improved muscle strength and recovery.

Elsewhere the page states clinical studies show ashwagandha “can increase testosterone by up to 17%.” The figure is used as a selling point twice.

What that trial actually used

The trial in question administered 600 mg per day of a standardised root extract, split across doses. That figure is not obscure — it is in the study title area, the methods, and every summary of it.

Most positive ashwagandha trials sit in the 300–600 mg range. Below roughly 250 mg the human evidence thins out considerably.

What the label carries

100 mg per gummy, at one gummy daily. That is approximately 17% of the cited trial dose — a coincidence of numbers that makes the comparison unusually easy to remember: the product delivers about the same percentage of the dose as the testosterone increase it advertises.

Why this matters more than it might seem

Citing research is legitimate and the page’s own disclaimer is careful, stating that references represent the general body of research on individual ingredients and are not intended to imply the finished product produces those results. Credit where due.

But that disclaimer sits at the bottom of the page, while the main body states that JellyBlue delivers “every active compound at its therapeutically effective dose” and mocks competitors for “underdosed fairy dust ingredients.” Those two positions cannot both be held about a formula carrying 100 mg of an ingredient whose cited trial used 600 mg.

What 100 mg might still do

Not nothing, necessarily. Ashwagandha’s effects appear dose-dependent rather than all-or-nothing, and some people respond at lower amounts. Standardisation matters too — a highly concentrated withanolide extract at 100 mg is not equivalent to 100 mg of plain root powder, and the label does not state which this is.

That is the honest position: it may do something, we cannot say how much, and it is certainly not the dose behind the number being advertised. If ashwagandha is your main reason for interest, a standalone standardised product at 300–600 mg costs a fraction of this and tells you exactly what you are getting.

Independent background reading, none of it selling anything: NHLBI on sleep, the Urology Care Foundation and NIH Office of Dietary Supplements. For the applied version of this on our own pages, see the full ingredient breakdown and interaction table or the JellyBlue official website reference.

What we would do

Take the label to a pharmacist before ordering, get a baseline blood panel so you have something to compare against, and choose the three-bottle package rather than the six — it covers the ninety days the seller itself recommends without leaving you holding four unopened bottles months after the refund window has closed. Diarise day 50 on the day you order.

How to verify any of this

Every figure above comes from a source you can check yourself: the printed Supplement Facts panel on the bottle, the official order page, the published return terms, or peer-reviewed literature. Where an amount is not disclosed by the manufacturer, we say so rather than estimating it. If you find something here that is out of date or wrong, tell us and we will re-check it and re-date the page.